Clinical Trial: A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition:
Advanced or Metastatic Solid Tumors
Non Small Cell Lung Cancer
NSCLC
Study Type: INTERVENTIONAL
Official Title: An Open-Label Phase 1 Dose-Escalation and Expansion Study Investigating the Safety, Pharmacokinetics, Pharmacodynamics, and Activity of PRTH-101 Alone or in Combination With Pembrolizumab in Adults Wi
Brief Summary:
The goal of this Open-Label Study is to evaluate the safety and tolerability of PRTH-101 alone or in combination with pembrolizumab in adults with advance or metastatic solid tumors.
Read more